Skip to content


Azopt (brinzolamide) is a small molecule pharmaceutical. Brinzolamide was first approved as Azopt on 1998-04-01. It is used to treat open-angle glaucoma in the USA. It has been approved in Europe to treat ocular hypertension and open-angle glaucoma. The pharmaceutical is active against carbonic anhydrase 7. In addition, it is known to target carbonic anhydrase 12, carbonic anhydrase 14, carbonic anhydrase 1, and carbonic anhydrase 2.
Trade Name Azopt
Common Name Brinzolamide
Indication ocular hypertension, open-angle glaucoma
Drug Class Carbonic anhydrase inhibitors
Get full access now